insights_auto
Why is SGMOQ up 7.42%?
Dive Deeperchevron_right
SGMOQ:OTCMKTS
Sangamo Therapeutics Inc
$0.15
arrow_upward
+7.42%(+0.010) 1D
Oct 9, 3:38:13 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SGMOQ...
Open
$0.14
High
$0.15
Low
$0.14
Mkt. cap
62.39M
Avg. vol.
1.90M
Volume
1.99M
52-wk high
$0.20
52-wk low
$0.03
EPS
-$0.38
Beta
1.56
Shares outstanding
414.29M
No. of employees
142
Open
$0.14
High
$0.15
Low
$0.14
Mkt. cap
62.39M
Avg. vol.
1.90M
Volume
1.99M
52-wk high
$0.20
52-wk low
$0.03
EPS
-$0.38
Beta
1.56
Shares outstanding
414.29M
No. of employees
142
News stories
From web sources and news partners
Yahoo Finance
·
1 hour ago
UPDATED: TruGolf Completes Acquisition of Polymath Research, Bringing a Blockchain Purpose-Built for Regulated Assets to Nasdaq
Seeking Alpha
·
1 hour ago
Digital payments firm OPay applies to list on NYSE
SpaceQ
·
50 minutes ago
NorthStar rings NYSE bell, adds U.S. technical director
Nasdaq
·
6 hours ago
WISeSat.Space Holdings Corp. Rings the Opening Bell
Profile
Sangamo Therapeutics, Inc. is an American biotechnology company based in Richmond, California, that develops cell and gene therapies for severe genetic diseases. Wikipedia
About Sangamo Therapeutics Inc
CEOSandy Macrae
Employees142
Founded1995
HeadquartersRichmond, California, United States
SectorBiotechnology
Websitesangamo.com